for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

YanAn Bicon Pharmaceutical Listed Co

002411.SZ

Latest Trade

16.98CNY

Change

-0.27(-1.57%)

Volume

10,917,100

Today's Range

16.98

 - 

17.33

52 Week Range

15.19

 - 

25.62

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
17.25
Open
17.28
Volume
10,917,100
3M AVG Volume
320.38
Today's High
17.33
Today's Low
16.98
52 Week High
25.62
52 Week Low
15.19
Shares Out (MIL)
1,532.28
Market Cap (MIL)
26,431.90
Forward P/E
37.50
Dividend (Yield %)
--

Latest Developments

More

Yanan Bicon Pharmaceutical's Shareholder And Parties Acting In Concert Plan To Cut Stake In The Company

YanAn Bicon Pharmaceutical's Executives Scrap Plan To Raise Stake, Unit To Sell Project

Yanan Bicon Pharmaceutical's Prelim 2018 Net Profit Down 51.85 Percent Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About YanAn Bicon Pharmaceutical Listed Co

YanAn Bicon Pharmaceutical Listed Company, formerly JiangSu Bicon Pharmaceutical Listed Company, is a China-based company principally engaged in the research and development, manufacture and distribution of medical products, new energy materials and drug intermediates. The Company operates its businesses through three segments. The Pharmaceuticals segment provides circulatory system, digestive system, respiratory system, nervous system and ophthalmic products. The New Materials segment mainly consists of lithium hexafluorophosphate, high-strength and high modulus polyethylene fibers and others. The Pharmaceutical Intermediates segment consists of 7-ADCA, benzaldehyde, 5.5-dimethylhydantion and trichloropyridine. The Company distributes its products mainly in domestic market.

Industry

Biotechnology & Drugs

Contact Info

North Building of Financial Bureau

No.18, Zhongwu South Road, Xinyi City

+86.516.88602411

Executive Leadership

Xingfu Xiang

President, Vice Chairman of the Board

Wen Dong

Finance Director

Bing Chen

Vice President, Secretary of the Board

Jun Guo

Vice President

Yudong He

Vice President

Key Stats

3.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2017

5.4K

2018

8.4K

2019(E)

9.8K
EPS (CNY)

2019(E)

0.460
Price To Earnings (TTM)
80.11
Price To Sales (TTM)
2.99
Price To Book (MRQ)
2.68
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
90.32
LT Debt To Equity (MRQ)
27.41
Return on Investment (TTM)
2.57
Return on Equity (TTM)
1.77

Latest News

MSCI lists 234 Chinese stocks for index inclusion in boost to capital markets

MSCI, the U.S. index publisher, said on Tuesday it will include 234 Chinese large cap stocks in its global and regional indexes on June 1, setting the stage for capital markets in the world's second-biggest economy to get a boost from a potential surge of foreign money.

BRIEF-Jiangsu Bicon Pharma In Deal To Sell Technology Unit To Risen Energy

* SAYS IT SCRAPS PLAN TO SELL ITS TECHNOLOGY UNIT TO SHENZHEN-BASED INVESTMENT FIRM DUE TO CHANGES IN MARKET CONDITIONS

BRIEF-JiangSu Bicon Pharmaceutical Listed unit receives GMP certificate

* Says its Shaanxi unit received goods manufacture practice (GMP) certificate from Shaanxi Food and Drug Administration

BRIEF-JiangSu Bicon Pharmaceutical Listed issues 2018 first tranche non-public corporate bonds worth 700 mln yuan

* Says it issues 2018 first tranche non-public corporate bonds worth 700 million yuan, with term of three years and coupon rate of 7.5 percent

BRIEF-JiangSu Bicon Pharmaceutical Listed sees FY 2018 H1 net profit to down 10 pct to up 20 pct

* Says it sees FY 2018 H1 net profit to decrease by 10 percent to increase by 20 percent, or to be 410.6 million yuan to 547.4 million yuan

BRIEF-JiangSu Bicon Pharmaceutical Listed unit to set up branches in Puyang and Shangqiu

* Says Henan-based unit plans to set up branches in Puyang and Shangqiu

BRIEF-Jiangsu Bicon Pharmaceutical Listed appoints Dong Wen as financial director

Jiangsu Bicon Pharmaceutical Listed Co : * Says it appoints Dong Wen as financial director Source text in Chinese: https://goo.gl/zniQox Further company coverage: (Beijing Headline News)

BRIEF-Jiangsu Bicon Pharmaceutical Says Board Elects Gu Xiaojia As Chairwoman

* SAYS BOARD ELECTS GU XIAOJIA AS CHAIRWOMAN Source text in Chinese: http://bit.ly/2Dan2M0 Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Jiangsu Bicon Pharmaceutical's Prelim 2017 Net Profit Down 1.45 Pct Y/Y

* SAYS PRELIM 2017 NET PROFIT DOWN 1.45 PERCENT Y/Y AT 939.82 MILLION YUAN Source text in Chinese: http://bit.ly/2BTr3aM Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Jiangsu Bicon Pharmaceutical to Sell Subsidiary, Unit Plans Acquisitions

* SAYS UNIT SIGNS FRAMEWORK AGREEMENT TO BUY STAKES IN THREE PHARMACY FIRMS FOR A COMBINED 350 MILLION YUAN

BRIEF-Jiangsu Bicon Pharmaceutical'ss Chairman Zhou Xinji Resigns

* SAYS CHAIRMAN ZHOU XINJI RESIGNS DUE TO CHANGE IN JOB ROLE Source text in Chinese: http://bit.ly/2ECmdjW Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Jiangsu Bicon Pharmaceutical obtains high-tech enterprise recognition

* Says it and unit will enjoy tax preference of 15 percent for three years

BRIEF-Jiangsu Bicon Pharmaceutical Listed unit passes review of high-tech enterprise recognition

* Says its wholly owned unit passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years

BRIEF-Jiangsu Bicon Pharmaceutical gets approval to issue commercial paper

* SAYS IT GETS APPROVAL TO ISSUE 1.0 BILLION YUAN ($151.56 million) ULTRA-SHORT COMMERCIAL PAPER Source text in Chinese: http://bit.ly/2AiaDpB Further company coverage: ($1 = 6.5982 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Jiangsu Bicon Pharmaceutical Listed sets up Jiangsu-based new energy unit with registered capital of 500 mln yuan

* Says it completed establishment of wholly owned new energy unit in Jiangsu, with a registered capital of 500 million yuan and the previous plan was disclosed on Oct. 23

BRIEF-Jiangsu Bicon Pharmaceutical's owner increases stake in the company

* Says its owner has bought 3.0 percent stake in the company between May 4 and Nov 23, taking his holdings to 15.62 percent after transaction

BRIEF-Jiangsu Bicon Pharmaceutical to set up buyout fund, issue bonds

* Says it plans to issue up to 3.0 billion yuan ($453.71 million) bonds

BRIEF- Jiangsu Bicon Pharmaceutical sees FY 2017 net profit to down 15 pct to up 15 pct

* Sees FY 2017 net profit to decrease by 15 percent to increase by 15 percent, or to be 810.6 million yuan to 1,096.7 million yuan

BRIEF-Jiangsu Bicon Pharmaceutical to set up new energy unit in Jiangsu

* Says it plans to use 500 million yuan to set up a wholly owned new energy subsidiary in Jiangsu province

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up